22 earlier Form 4 trades (code P or S) here by this insider (22 buys), the last on Dec 4, 2025.
-7.3% median (-1.7% mean) 90-day return after 22 previous buys.
The trade is 2.2% of the 849,642 shares held after it.
No other insider bought within 30 days.
47 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Malhotra Rohan bought about $26.1K of RDZN on Mar 2, 2026, the largest insider purchase at the company since 2023; 47 funds added in the latest 13F quarter.
19 earlier Form 4 trades (code P or S) here by this insider (19 buys), the last on Mar 7, 2025.
-3.4% median (+0.3% mean) 90-day return after 19 previous buys.
The trade is 0.3% of the 807,837 shares held after it.
1 other insider bought within 30 days.
47 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Malhotra Rohan bought about $2.5K of RDZN on Mar 12, 2025; 1 other insider bought within 30 days and 47 funds added in the latest 13F quarter.
18 earlier Form 4 trades (code P or S) here by this insider (18 buys), the last on Mar 6, 2025.
-3.4% median (+0.5% mean) 90-day return after 18 previous buys.
The trade is 0.2% of the 805,537 shares held after it.
1 other insider bought within 30 days.
47 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Malhotra Rohan bought about $2.2K of RDZN on Mar 7, 2025; 1 other insider bought within 30 days and 47 funds added in the latest 13F quarter.
34 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$60.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM RDZN
FY Mar 2026
$55.0M
FY Mar 2025
$44.3M
FY Mar 2024
$46.7M
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
$16.2M
Mar 2026
$16.1M
Dec 2025
$14.4M
Sep 2025
$13.7M
Jun 2025
$10.9M
Mar 2025
$11.4M
Dec 2024
$12.1M
Sep 2024
$11.9M
At each fiscal year end
Single quarter
Net margin, TTM
-46.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM RDZN
FY Mar 2026
-40.9%
FY Mar 2025
-164.5%
FY Mar 2024
-213.3%
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
-60.5%
Mar 2026
-45.0%
Dec 2025
-63.7%
Sep 2025
-15.4%
Jun 2025
-36.9%
Mar 2025
-1.2%
Dec 2024
-20.8%
Sep 2024
-183.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
-$5.9M
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-$3.2M
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.87x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt RDZN
FY Mar 2026
-0.80x
FY Mar 2025
-5.96x
FY Mar 2024
-5.19x
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
-0.87x
Mar 2026
-0.80x
Dec 2025
-1.90x
Sep 2025
-1.50x
Jun 2025
-5.03x
Mar 2025
-5.96x
Dec 2024
-5.59x
Sep 2024
-4.32x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-70.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RDZN
FY Mar 2026
-52.8%
FY Mar 2025
-160.7%
FY Mar 2024
-271.9%
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
-70.2%
Mar 2026
-52.8%
Dec 2025
-40.1%
Sep 2025
-24.8%
Jun 2025
-84.9%
Mar 2025
-160.7%
Dec 2024
-216.4%
Sep 2024
-284.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
capital employed is zero or negative
Return on capital employed RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$116.5M
market value at close 2026-10-26 on 2026-08-12 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value RDZN
FY Mar 2026
$114.5M
FY Mar 2025
$75.4M
FY Mar 2024
$437.4M
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
$143.7M
Mar 2026
$114.5M
Dec 2025
$196.3M
Sep 2025
$71.3M
Jun 2025
$72.7M
Mar 2025
$75.4M
Dec 2024
$146.8M
Sep 2024
$79.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing RDZN
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Dec 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
RDZN ranks highest on growth (77th percentile) and risk and compliance (53rd), and lowest on financial health (2nd), among Insurance peers.
Financial health
2
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt-0.87x · 2 pct, sector of 97
Growth
77
Inputs
Revenue growth, YoY+24.2% · 77 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
20
Inputs
Funds adding, latest quarter47 · 20 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
53
Inputs
Short interest, % of float+8.0% · 17 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+4.3% · 89 pct, sector of 110
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; pre-tax loss, no effective tax rate to apply
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.